טופמקס ספרינקל 25 מ"ג כמוסות

Pays: Israël

Langue: hébreu

Source: Ministry of Health

Ingrédients actifs:

TOPIRAMATE 25 MG

Disponible depuis:

J-C HEALTH CARE LTD

Code ATC:

N03AX11

forme pharmaceutique:

CAPSULES

Mode d'administration:

PER OS

Fabriqué par:

JANSSEN CILAG S.P.A., ITALY

Groupe thérapeutique:

TOPIRAMATE

indications thérapeutiques:

In adjunctive therapy of adults and children (from 2 years) with partial seizures and generalized tonic-clonic seizures. In adjunctive therapy of seizures with Lennox-Gastaut syndrome in adults and children. Topamax is indicated as monotherapy in patients with newly diagnosed epilepsy in children aged 7 years and above or for conversion to monotherapy in patients with epilepsy. Topamax is indicated in adults for the prevention of migraines. The use of Topamax in the acute treatment of migraine has not been studied.

Date de l'autorisation:

2012-02-01